Protein Discovery

Protein Discovery is a biotechnology company that specializes in pioneering the future of protein and peptide analysis with innovative sample preparation technologies for mass spectrometry. The company, initially established as Qgenics Biosciences, Inc. in 2001 and rebranded to Protein Discovery, Inc. in April 2004, is headquartered in Knoxville, Tennessee. Protein Discovery's key products include the Gelfree 8100, a technology that fractionates complex protein mixtures into liquid-phase molecular weight fractions, the Passport 1200, which enriches low molecular weight proteins and peptides, and the PPS Silent Surfactant, offering enhanced protein preparation by solubilizing membrane proteins and preventing detergent interference. The company also offers the UPX universal protein extraction kit for detergent extraction of proteins from cells and tissues. The latest notable investment in Protein Discovery was a $10.00M Series C investment on 24 March 2008, with contributions from Santé Ventures, MB Venture Partners, Nashville Capital Network, and The Southern Appalachian Fund. The company serves life science researchers and drug development scientists, distributing its products via Agilent Technologies and online, both in the United States and globally. Overall, Protein Discovery stands out for its focus on equipping researchers with advanced tools for protein and peptide analysis, backed by notable investments and a strong network of investors.